Literature DB >> 24873730

Spatiotemporally limited BDNF and GDNF overexpression rescues motoneurons destined to die and induces elongative axon growth.

Gholam Pajenda1, David Hercher2, Gábor Márton3, Krisztián Pajer3, Georg A Feichtinger2, József Maléth3, Heinz Redl2, Antal Nógrádi4.   

Abstract

Axonal injury close to cell bodies of motoneurons induces the death of the vast majority of affected cells. Neurotrophic factors, such as brain derived neurotrophic factor (BDNF) and glial cell derived neurotrophic factor (GDNF), delivered close to the damaged motor pool in a non-regulated manner induce good survival of injured motoneurons and sprouting of their axons but fail to induce functional reinnervation. To avoid these drawbacks of high levels of neurotrophic expression, we devised an ex vivo gene therapy system to induce transient expression of BDNF/GDNF in transfected rat adipose tissue-derived stem cells (rASCs) which were grafted around the reimplanted ventral root, embedded in collagen gel. Strong BDNF/GDNF expression was induced in vitro in the first days after transfection with a significant decline in expression 10-14 days following transfection. Numerous axons of injured motoneurons were able to enter the reimplanted root following reimplantation and BDNF or GDNF treatment (192±17 SEM vs 187±12 SEM, respectively) and produce morphological and functional reinnervation. Treatment with a combined cell population (BDNF+GDNF-transfected rASCs) induced slightly improved reinnervation (247±24 SEM). In contrast, only few motoneurons regenerated their axons in control animals (63±4 SEM) which received untransfected cells. The axons of surviving motoneurons showed elongative growth typical of regenerative axons, without aberrant growth or coil formation of sprouting axons. These findings provide evidence that damaged motoneurons require limited and spatially directed amounts of BDNF and GDNF to support their survival and regeneration. Moreover, neurotrophic support appears to be needed only for a critical period of time not longer than for two weeks after injury.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipose tissue-derived stem cells; Axonal growth; BDNF; GDNF; Reinnervation; Transfection; Ventral root avulsion

Mesh:

Substances:

Year:  2014        PMID: 24873730     DOI: 10.1016/j.expneurol.2014.05.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

1.  Finely Tuned Temporal and Spatial Delivery of GDNF Promotes Enhanced Nerve Regeneration in a Long Nerve Defect Model.

Authors:  Laura M Marquardt; Xueping Ee; Nisha Iyer; Daniel Hunter; Susan E Mackinnon; Matthew D Wood; Shelly E Sakiyama-Elbert
Journal:  Tissue Eng Part A       Date:  2015-12       Impact factor: 3.845

2.  Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.

Authors:  Rafael Coelho Magalhães; Janaina Matos Moreira; Érica Leandro Marciano Vieira; Natália Pessoa Rocha; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Mediators Inflamm       Date:  2017-05-02       Impact factor: 4.711

3.  Intravenous Transplantation of Mesenchymal Stem Cells Reduces the Number of Infiltrated Ly6C+ Cells but Enhances the Proportions Positive for BDNF, TNF-1α, and IL-1β in the Infarct Cortices of dMCAO Rats.

Authors:  Yunqian Guan; Xiaobo Li; Wenxiu Yu; Zhaohui Liang; Min Huang; Renchao Zhao; Chunsong Zhao; Yao Liu; Haiqiang Zou; Yanli Hao; Zhiguo Chen
Journal:  Stem Cells Int       Date:  2018-10-02       Impact factor: 5.443

Review 4.  The Role of Metals in the Neuroregenerative Action of BDNF, GDNF, NGF and Other Neurotrophic Factors.

Authors:  Vincenzo Giuseppe Nicoletti; Krisztián Pajer; Damiano Calcagno; Gholam Pajenda; Antal Nógrádi
Journal:  Biomolecules       Date:  2022-07-22

5.  Gene therapy and peripheral nerve repair: a perspective.

Authors:  Stefan A Hoyng; Fred de Winter; Martijn R Tannemaat; Bas Blits; Martijn J A Malessy; Joost Verhaagen
Journal:  Front Mol Neurosci       Date:  2015-07-15       Impact factor: 5.639

6.  Growth factor choice is critical for successful functionalization of nanoparticles.

Authors:  Josephine Pinkernelle; Vittoria Raffa; Maria P Calatayud; Gerado F Goya; Cristina Riggio; Gerburg Keilhoff
Journal:  Front Neurosci       Date:  2015-09-02       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.